HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-AUG-10 3OG7 TITLE B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AKAP9-BRAF FUSION PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 1175-1446); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS B-RAF, BRAF, PROTO-ONCOGENE, V600E, KINASE, TRANSFERASE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHANG,K.Y.ZHANG,C.ZHANG REVDAT 5 21-FEB-24 3OG7 1 REMARK SEQADV HETSYN REVDAT 4 02-MAY-18 3OG7 1 HEADER KEYWDS REVDAT 3 25-OCT-17 3OG7 1 HETSYN REVDAT 2 06-OCT-10 3OG7 1 JRNL REVDAT 1 22-SEP-10 3OG7 0 JRNL AUTH G.BOLLAG,P.HIRTH,J.TSAI,J.ZHANG,P.N.IBRAHIM,H.CHO,W.SPEVAK, JRNL AUTH 2 C.ZHANG,Y.ZHANG,G.HABETS,E.A.BURTON,B.WONG,G.TSANG,B.L.WEST, JRNL AUTH 3 B.POWELL,R.SHELLOOE,A.MARIMUTHU,H.NGUYEN,K.Y.ZHANG, JRNL AUTH 4 D.R.ARTIS,J.SCHLESSINGER,F.SU,B.HIGGINS,R.IYER,K.D'ANDREA, JRNL AUTH 5 A.KOEHLER,M.STUMM,P.S.LIN,R.J.LEE,J.GRIPPO,I.PUZANOV, JRNL AUTH 6 K.B.KIM,A.RIBAS,G.A.MCARTHUR,J.A.SOSMAN,P.B.CHAPMAN, JRNL AUTH 7 K.T.FLAHERTY,X.XU,K.L.NATHANSON,K.NOLOP JRNL TITL CLINICAL EFFICACY OF A RAF INHIBITOR NEEDS BROAD TARGET JRNL TITL 2 BLOCKADE IN BRAF-MUTANT MELANOMA. JRNL REF NATURE V. 467 596 2010 JRNL REFN ISSN 0028-0836 JRNL PMID 20823850 JRNL DOI 10.1038/NATURE09454 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.5_2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 21223 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.190 REMARK 3 FREE R VALUE TEST SET COUNT : 1146 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 21.2756 - 4.8839 0.94 2744 156 0.1766 0.2014 REMARK 3 2 4.8839 - 3.8842 0.95 2646 129 0.1679 0.2228 REMARK 3 3 3.8842 - 3.3955 0.95 2639 130 0.2012 0.2405 REMARK 3 4 3.3955 - 3.0861 0.95 2615 142 0.2319 0.2977 REMARK 3 5 3.0861 - 2.8654 0.95 2581 142 0.2690 0.3498 REMARK 3 6 2.8654 - 2.6968 0.95 2581 137 0.2837 0.3466 REMARK 3 7 2.6968 - 2.5620 0.95 2602 129 0.3023 0.3415 REMARK 3 8 2.5620 - 2.4507 0.94 2570 142 0.3323 0.3173 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 47.40 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 24.09380 REMARK 3 B22 (A**2) : -6.25230 REMARK 3 B33 (A**2) : -17.84150 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.0860 REMARK 3 OPERATOR: -H,L,K REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4119 REMARK 3 ANGLE : 0.649 5553 REMARK 3 CHIRALITY : 0.048 600 REMARK 3 PLANARITY : 0.004 707 REMARK 3 DIHEDRAL : 16.634 1535 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -1.3512 -12.8290 -19.0118 REMARK 3 T TENSOR REMARK 3 T11: 0.2830 T22: 0.1799 REMARK 3 T33: 0.1414 T12: 0.0279 REMARK 3 T13: 0.0065 T23: -0.0149 REMARK 3 L TENSOR REMARK 3 L11: 0.4271 L22: 0.5813 REMARK 3 L33: 0.3905 L12: 0.2092 REMARK 3 L13: 0.1909 L23: 0.5345 REMARK 3 S TENSOR REMARK 3 S11: 0.0295 S12: 0.1294 S13: 0.0517 REMARK 3 S21: 0.4450 S22: 0.0815 S23: 0.0308 REMARK 3 S31: 0.2817 S32: 0.0987 S33: -0.0896 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 1.4917 8.6212 6.0490 REMARK 3 T TENSOR REMARK 3 T11: -0.0793 T22: 0.1906 REMARK 3 T33: 0.0369 T12: 0.0770 REMARK 3 T13: 0.1264 T23: -0.0440 REMARK 3 L TENSOR REMARK 3 L11: 0.9070 L22: -0.0294 REMARK 3 L33: 1.4032 L12: 0.0673 REMARK 3 L13: -0.0545 L23: 0.1136 REMARK 3 S TENSOR REMARK 3 S11: -0.0650 S12: -0.0999 S13: 0.5313 REMARK 3 S21: 0.1643 S22: -0.0917 S23: -0.0431 REMARK 3 S31: 0.6296 S32: 0.1890 S33: 0.1035 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN L AND RESSEQ 1:1 REMARK 3 ORIGIN FOR THE GROUP (A): 1.8508 -2.7808 -20.0870 REMARK 3 T TENSOR REMARK 3 T11: 0.2232 T22: 0.2843 REMARK 3 T33: 0.2448 T12: 0.0830 REMARK 3 T13: 0.0676 T23: 0.0568 REMARK 3 L TENSOR REMARK 3 L11: 0.3324 L22: 0.2201 REMARK 3 L33: 0.0130 L12: 0.0881 REMARK 3 L13: 0.0256 L23: 0.0536 REMARK 3 S TENSOR REMARK 3 S11: 0.0039 S12: -0.0108 S13: 0.0148 REMARK 3 S21: -0.0181 S22: -0.0394 S23: 0.0296 REMARK 3 S31: 0.0173 S32: 0.0067 S33: 0.0485 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OG7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000061075. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 3.3.15 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22230 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 110.128 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.52400 REMARK 200 R SYM FOR SHELL (I) : 0.52400 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BISTRIS AT PH 6.0, 12.5% 2,5 REMARK 280 -HEXANEDIOL, AND 12% PEG3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.38500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.06400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.21200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.06400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.38500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.21200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 432 REMARK 465 LYS A 433 REMARK 465 LYS A 434 REMARK 465 GLY A 435 REMARK 465 HIS A 436 REMARK 465 HIS A 437 REMARK 465 HIS A 438 REMARK 465 HIS A 439 REMARK 465 HIS A 440 REMARK 465 HIS A 441 REMARK 465 GLY A 442 REMARK 465 SER A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 ALA A 446 REMARK 465 ALA A 447 REMARK 465 ASP A 448 REMARK 465 GLU A 545 REMARK 465 THR A 546 REMARK 465 LYS A 547 REMARK 465 LEU A 597 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 GLU A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 MET A 627 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 SER A 630 REMARK 465 MET B 432 REMARK 465 LYS B 433 REMARK 465 LYS B 434 REMARK 465 GLY B 435 REMARK 465 HIS B 436 REMARK 465 HIS B 437 REMARK 465 HIS B 438 REMARK 465 HIS B 439 REMARK 465 HIS B 440 REMARK 465 HIS B 441 REMARK 465 GLY B 442 REMARK 465 SER B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 ALA B 446 REMARK 465 ALA B 447 REMARK 465 ASP B 448 REMARK 465 LYS B 601 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 MET B 627 REMARK 465 GLN B 628 REMARK 465 ASP B 629 REMARK 465 SER B 630 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 453 151.21 -47.95 REMARK 500 ARG A 575 -15.01 78.91 REMARK 500 ASP A 576 55.71 -154.93 REMARK 500 ASN A 660 56.53 -91.77 REMARK 500 ASN A 684 36.26 -75.66 REMARK 500 TRP B 476 92.18 -160.90 REMARK 500 THR B 521 -59.15 -129.61 REMARK 500 ALA B 522 21.78 -74.49 REMARK 500 PRO B 523 -87.45 -114.92 REMARK 500 ALA B 543 30.14 -91.55 REMARK 500 ASP B 576 38.22 -154.00 REMARK 500 ASP B 587 -15.42 76.91 REMARK 500 PHE B 595 -84.66 -52.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA B 522 PRO B 523 143.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 032 A 1 DBREF 3OG7 A 449 720 UNP Q5IBP5 Q5IBP5_HUMAN 1175 1446 DBREF 3OG7 B 449 720 UNP Q5IBP5 Q5IBP5_HUMAN 1175 1446 SEQADV 3OG7 MET A 432 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 LYS A 433 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 LYS A 434 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 GLY A 435 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 436 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 437 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 438 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 439 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 440 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS A 441 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 GLY A 442 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 SER A 443 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ARG A 444 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ASP A 445 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA A 446 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA A 447 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ASP A 448 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA A 522 UNP Q5IBP5 LYS 1248 ENGINEERED MUTATION SEQADV 3OG7 ALA A 543 UNP Q5IBP5 ILE 1269 ENGINEERED MUTATION SEQADV 3OG7 SER A 544 UNP Q5IBP5 ILE 1270 ENGINEERED MUTATION SEQADV 3OG7 LYS A 551 UNP Q5IBP5 ILE 1277 ENGINEERED MUTATION SEQADV 3OG7 ARG A 562 UNP Q5IBP5 GLN 1288 ENGINEERED MUTATION SEQADV 3OG7 ASN A 588 UNP Q5IBP5 LEU 1314 ENGINEERED MUTATION SEQADV 3OG7 GLU A 600 UNP Q5IBP5 VAL 1326 VARIANT SEQADV 3OG7 SER A 630 UNP Q5IBP5 LYS 1356 ENGINEERED MUTATION SEQADV 3OG7 GLU A 667 UNP Q5IBP5 PHE 1393 ENGINEERED MUTATION SEQADV 3OG7 SER A 673 UNP Q5IBP5 TYR 1399 ENGINEERED MUTATION SEQADV 3OG7 ARG A 688 UNP Q5IBP5 ALA 1414 ENGINEERED MUTATION SEQADV 3OG7 SER A 706 UNP Q5IBP5 LEU 1432 ENGINEERED MUTATION SEQADV 3OG7 ARG A 709 UNP Q5IBP5 GLN 1435 ENGINEERED MUTATION SEQADV 3OG7 GLU A 713 UNP Q5IBP5 SER 1439 ENGINEERED MUTATION SEQADV 3OG7 GLU A 716 UNP Q5IBP5 LEU 1442 ENGINEERED MUTATION SEQADV 3OG7 GLU A 720 UNP Q5IBP5 SER 1446 ENGINEERED MUTATION SEQADV 3OG7 MET B 432 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 LYS B 433 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 LYS B 434 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 GLY B 435 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 436 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 437 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 438 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 439 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 440 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 HIS B 441 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 GLY B 442 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 SER B 443 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ARG B 444 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ASP B 445 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA B 446 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA B 447 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ASP B 448 UNP Q5IBP5 EXPRESSION TAG SEQADV 3OG7 ALA B 522 UNP Q5IBP5 LYS 1248 ENGINEERED MUTATION SEQADV 3OG7 ALA B 543 UNP Q5IBP5 ILE 1269 ENGINEERED MUTATION SEQADV 3OG7 SER B 544 UNP Q5IBP5 ILE 1270 ENGINEERED MUTATION SEQADV 3OG7 LYS B 551 UNP Q5IBP5 ILE 1277 ENGINEERED MUTATION SEQADV 3OG7 ARG B 562 UNP Q5IBP5 GLN 1288 ENGINEERED MUTATION SEQADV 3OG7 ASN B 588 UNP Q5IBP5 LEU 1314 ENGINEERED MUTATION SEQADV 3OG7 GLU B 600 UNP Q5IBP5 VAL 1326 VARIANT SEQADV 3OG7 SER B 630 UNP Q5IBP5 LYS 1356 ENGINEERED MUTATION SEQADV 3OG7 GLU B 667 UNP Q5IBP5 PHE 1393 ENGINEERED MUTATION SEQADV 3OG7 SER B 673 UNP Q5IBP5 TYR 1399 ENGINEERED MUTATION SEQADV 3OG7 ARG B 688 UNP Q5IBP5 ALA 1414 ENGINEERED MUTATION SEQADV 3OG7 SER B 706 UNP Q5IBP5 LEU 1432 ENGINEERED MUTATION SEQADV 3OG7 ARG B 709 UNP Q5IBP5 GLN 1435 ENGINEERED MUTATION SEQADV 3OG7 GLU B 713 UNP Q5IBP5 SER 1439 ENGINEERED MUTATION SEQADV 3OG7 GLU B 716 UNP Q5IBP5 LEU 1442 ENGINEERED MUTATION SEQADV 3OG7 GLU B 720 UNP Q5IBP5 SER 1446 ENGINEERED MUTATION SEQRES 1 A 289 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER ARG SEQRES 2 A 289 ASP ALA ALA ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE SEQRES 3 A 289 THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR SEQRES 4 A 289 VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS SEQRES 5 A 289 MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN SEQRES 6 A 289 ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG SEQRES 7 A 289 HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR ALA SEQRES 8 A 289 PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SEQRES 9 A 289 SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR LYS PHE SEQRES 10 A 289 GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN THR ALA SEQRES 11 A 289 ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS SEQRES 12 A 289 ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP SEQRES 13 A 289 ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU SEQRES 14 A 289 LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SEQRES 15 A 289 SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG SEQRES 16 A 289 MET GLN ASP SER ASN PRO TYR SER PHE GLN SER ASP VAL SEQRES 17 A 289 TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY SEQRES 18 A 289 GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE SEQRES 19 A 289 ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO ASP LEU SEQRES 20 A 289 SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET LYS ARG SEQRES 21 A 289 LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG SEQRES 22 A 289 PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU GLU LEU SEQRES 23 A 289 ALA ARG GLU SEQRES 1 B 289 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER ARG SEQRES 2 B 289 ASP ALA ALA ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE SEQRES 3 B 289 THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR SEQRES 4 B 289 VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS SEQRES 5 B 289 MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN SEQRES 6 B 289 ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG SEQRES 7 B 289 HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR ALA SEQRES 8 B 289 PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SEQRES 9 B 289 SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR LYS PHE SEQRES 10 B 289 GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN THR ALA SEQRES 11 B 289 ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS SEQRES 12 B 289 ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP SEQRES 13 B 289 ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU SEQRES 14 B 289 LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SEQRES 15 B 289 SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG SEQRES 16 B 289 MET GLN ASP SER ASN PRO TYR SER PHE GLN SER ASP VAL SEQRES 17 B 289 TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY SEQRES 18 B 289 GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE SEQRES 19 B 289 ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO ASP LEU SEQRES 20 B 289 SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET LYS ARG SEQRES 21 B 289 LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG SEQRES 22 B 289 PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU GLU LEU SEQRES 23 B 289 ALA ARG GLU HET 032 A 1 33 HETNAM 032 N-(3-{[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3- HETNAM 2 032 YL]CARBONYL}-2,4-DIFLUOROPHENYL)PROPANE-1-SULFONAMIDE HETSYN 032 VEMURAFENIB; PLX4032 FORMUL 3 032 C23 H18 CL F2 N3 O3 S FORMUL 4 HOH *65(H2 O) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 LEU A 537 HIS A 542 1 6 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 ALA A 621 ARG A 626 1 6 HELIX 5 5 SER A 634 GLY A 652 1 19 HELIX 6 6 ASN A 661 ARG A 671 1 11 HELIX 7 7 PRO A 686 LEU A 697 1 12 HELIX 8 8 LYS A 700 ARG A 704 5 5 HELIX 9 9 SER A 706 LEU A 717 1 12 HELIX 10 10 THR B 491 ARG B 506 1 16 HELIX 11 11 SER B 536 HIS B 542 1 7 HELIX 12 12 GLU B 549 LYS B 570 1 22 HELIX 13 13 GLU B 586 ASN B 588 5 3 HELIX 14 14 GLY B 615 MET B 620 5 6 HELIX 15 15 ALA B 621 ARG B 626 1 6 HELIX 16 16 SER B 634 GLY B 652 1 19 HELIX 17 17 ASN B 661 GLY B 672 1 12 HELIX 18 18 ASP B 677 VAL B 681 5 5 HELIX 19 19 PRO B 686 LEU B 697 1 12 HELIX 20 20 LYS B 700 ARG B 704 5 5 HELIX 21 21 SER B 706 GLU B 720 1 15 SHEET 1 A 5 THR A 458 SER A 465 0 SHEET 2 A 5 GLY A 469 LYS A 475 -1 O VAL A 471 N ILE A 463 SHEET 3 A 5 ASP A 479 LEU A 485 -1 O VAL A 480 N GLY A 474 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 A 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 5 THR B 458 SER B 465 0 SHEET 2 C 5 THR B 470 LYS B 475 -1 O LYS B 473 N GLY B 460 SHEET 3 C 5 ASP B 479 LEU B 485 -1 O MET B 484 N THR B 470 SHEET 4 C 5 LEU B 525 GLN B 530 -1 O THR B 529 N ALA B 481 SHEET 5 C 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O THR B 589 N HIS B 585 CISPEP 1 ALA A 522 PRO A 523 0 -0.27 SITE 1 AC1 13 VAL A 471 ALA A 481 LYS A 483 LEU A 505 SITE 2 AC1 13 LEU A 514 THR A 529 GLN A 530 TRP A 531 SITE 3 AC1 13 CYS A 532 PHE A 583 ASP A 594 PHE A 595 SITE 4 AC1 13 GLY A 596 CRYST1 50.770 104.424 110.128 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019697 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009576 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009080 0.00000